1-3 of 3
Kirit M Ardeshna, FRCPath
Close
Sort by
Journal Articles

Treatment Of Non-Hodgkin’s Lymphoma With Secondary Central Nervous System Involvement: Encouraging Response Rates Using CNS-Penetrating Idaram Chemotherapy

Paul M Maciocia, MRCP, Mohsin Badat, MB BChir, Simon Cheesman, Jonathan Lambert, MD, Martin Pule, MD, David C. Linch, FRCP, Kirit M Ardeshna, FRCPath
Journal: Blood
Blood (2013) 122 (21): 4367.
https://doi.org/10.1182/blood.V122.21.4367.4367
Published: 2013
Journal Articles

Rituximab and CODOX-M / IVAC Without Stem Cell Transplantation For Poor Risk Diffuse Large B Cell Lymphoma (IPI3-5) and Burkitts Lymphoma Is Feasible and Gives a High Response Rate: Preliminary Results Of a Phase 2 UK National Cancer Research Institute Trial

Andrew McMillan, FRCP, FRCPath, PhD, Kirit M Ardeshna, FRCPath, Jo Gambell, Andrew Jack, PhD, Amy Kirkwood, Anthony Laurie, Silvia Montoto, MD, Shankaranarayana Paneesha, MD, Simon Rule, MD, Russell Patmore, MD, Ruth Pettengell, Humra Shah, Paul Smith, David Linch, FMedSci
Journal: Blood
Blood (2013) 122 (21): 4348.
https://doi.org/10.1182/blood.V122.21.4348.4348
Published: 2013
Journal Articles

Prognostic Effect Of More Than 1 Extranodal Site Of Disease For Patients With Diffuse Large B Cell Lymphoma (DLBCL) In The Rituximab Era: Results From The UK NCRI R-CHOP 14 Versus 21 Trial

Mary Gleeson, FRCPath, Wendi Qian, PhD, David Cunningham, FMedSci, Eliza Hawkes, FRACP, Andrew Jack, PhD, Paul Smith, MSc, Paul Mouncey, MSc, Christopher Pocock, PhD, Kirit M Ardeshna, FRCPath, John Radford, MD, Andrew McMillan, FRCPath, John Davies, FRCPE, Deborah Turner, FRCPath, Anton Kruger, FRCPath, Peter Johnson, FRCP, Joanna Gambell, BSc, David Linch, FMedSci
Journal: Blood
Blood (2013) 122 (21): 4268.
https://doi.org/10.1182/blood.V122.21.4268.4268
Published: 2013